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ABSTRACT 
Bacterial infections have posed a serious threat to the public health due to the significant 
rise of the infections caused by antibiotic resistant bacteria. There has been considerable interest 
in the development of antimicrobial agents which mimic the natural HDPs, and among them 
biodegradable polymers are newly discovered drug candidates with ease of synthesis and low 
manufacture cost compared to synthetic host defense peptides. Herein, we present the synthesis of 
biocompatible and biodegradable polymers including polycarbonate polymers, unimolecular 
micelle hyperbranched polymers and dendrimers that mimic the antibacterial mechanism of HDPs 
by compromising bacterial cell membranes. The developed amphiphilic polycarbonates are highly 
selective to Gram-positive bacteria, including multidrug resistant pathogens and the unimolecular 
micelle hyperbranched polymers showed promising broad-spectrum activity. However, lipidated 
amphiphilic dendrimers with low molecular weight display potent and selective antimicrobial 
activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant 
strains. In addition to antibacterial activity against planktonic bacteria, these dendrimers were also 
shown to inhibit bacterial biofilms effectively. These class of polymers may lead to a useful 
generation of antibiotic agents with practical applications. 
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CHAPTER 1: INTRODUCTION 
1.1 Introduction  
Antibiotics are agents that can be produced by microorganisms and have the capacity to 
inhibit the growth of similar microorganisms. In the history of medicine, antimicrobials are one of 
the most powerful forms of chemotherapy. With the discovery of new antibiotics, the death rate 
caused by infectious diseases was decreased from 797 per hundred thousand in 1900 to 36 per 
hundred thousand in 1980.1 However, although the number of discovered antibacterial medications 
continues to grow, bacterial resistance to many of these medications become a threat to the current 
prevention and treatment of infections. Indeed, within the past twenty years, bacterial resistance 
has been considered the greatest challenge to the antibiotic era; 30% of all deaths in America was 
due to tuberculosis, pneumonia and gastrointestinal infections caused by resistant bacteria.2 
Antibiotic resistance can occur via three general mechanisms.3 First, bacterial destruction 
to the antibiotics by specific enzymes for instance some bacteria produce beta lactamase enzyme 
which degrades beta lactam drugs. Another approach to drug resistance is when bacteria undergo 
mutational changes in their structural and functional makeup by acquiring new genes from other 
strains. This results in changes in the bacterial receptor conformation which leads to less 
susceptibility of the bacteria towards the drug. An example of this type of bacterial resistance is 
mostly shown by Vancomycin-resistant Enterococcus. The third major course of bacterial 
resistance is through overexpression of several efflux pumps which leads to banishing of the drugs 
from the bacterial cell which results in a decrease in concentration of the drug to a level which is 
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below the toxic threshold. An example of this mechanism is shown by gram-positive and gram-
negative bacteria but mainly by Pseudomonas bacterial strains.2,3,4 
One of the promising ongoing research topics to address the challenges created by the 
resistant bacteria is to mimic host defense peptides (HDP) by unnatural peptidomimetics including 
β-peptides,5 peptoids,6 oligoureas,7 AApeptides.8 Small peptidomimetics can mimic the function 
and mechanism of natural HDPs and have shown promising potent, broad spectrum antimicrobial 
activity. HDPs, however, are generally not cost effective, as it is difficult to scale up the reaction 
to produce in extensive quantities.9 Recently, polymers such as methacrylates,10 norborenene,11 
amidoamines,12 polystyrenes,  polycarbonates13, Dendrimers14 and hyperbranched unimolecular 
nanoparticles15  are getting more attention as novel anti-infective candidates.  
Polymers are macromolecular compounds composed of repeating units of monomers 
which are linked to each other with a chemical bond. Polymers are currently becoming main 
interest of the biomedical era.16 With the current innovations in polymer chemistry, polymers are 
functionalized in various architectural designs, including dendrimers and unimolecular micelles. 
Dendrimers are highly branched globular structures consisting of a central core from which 
identical fragments are built up to make star-like macromolecular structures.17  
1.2 Outline of the Thesis 
In this thesis, we discuss the design, synthesis, and antibacterial application of biodegradable 
polymers.  
In chapter 2, we studied the design and antibacterial activity of amphiphilic peptide-based 
polycarbonate polymers. 
In chapter 3, we discuss the design, solid phase synthesis and the antibacterial activity of 
lipidated dendrimers  
3 
 
 In chapter 4, we describe the design, development and antibacterial activity of unimolecular 
micelle nanoparticle. 
  In chapter 5, we recapitulate the research findings and conclude the future directions of our 
research study. 
1.3 Reference 
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(2015). 
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CHAPTER 2: PEPTIDE BASED POLYCARBONATE POLYMERS  WITH POTENT AND 
SELECTIVE ANTIMICROBIAL ACTIVITY 
2.1 Introduction 
Natural antimicrobial peptides (HDPs) are one of the first lines of defense within our body 
when bacteria or other microbes attack the body. They have broad-spectrum antimicrobial 
activities.1 HDPs are found in many species, including humans, animals, plants, and invertebrates. 
The mechanism of action for these peptides are not receptor-based interaction, but through direct 
action on the bacteria’s membranes.2 The slowly progressing development of replacements for the 
current ineffective antibiotic treatment results in a major risk to public health through multidrug 
resistant bacteria. Different studies have revealed that bacteria can develop resistance to drugs in 
numerous ways including effluxing the drug from inside the cell through membrane bounded 
pumping proteins, undergoing mutational changes within the main receptors of the drug, and 
developing enzymes which can selectively degrade the antibiotics.3 Presently, to face the 
challenges caused by the multi-drug resistant bacteria various novel antimicrobial agents have 
been developed. Compounds having cationic groups have arisen as auspicious candidates to 
replace the current antibacterial drugs which already faced resistance. This is due to the short 
amphiphilic positively charged peptides have the tendency to mimic HDPs and are selective 
towards bacteria. Presently researchers are mainly working on synthetic peptides, polymers and 
lipids as potential cationic compounds.4 Herein we report the synthesis and antimicrobial 
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application of peptide based polycarbonate polymers, in continuation to projects previously done 
in our lab.5  
2.2 General Overview of Polymers.  
Polymers are large macromolecules consisting of repeating units, named monomers, linked 
together through a covalent bond. Polymers can be obtained from natural sources called natural 
polymers or artificially synthesized like that of synthetic polymers. Polymers have diverse 
structural arrangements, ranging from linear to branched and cross-linked arrangement. Linear 
polymers have long and straight chained arrangements like polyethylene and polyvinyl chloride. 
Branched polymers contain some branches on the linear backbone, furthermore  cross-linked 
polymers are formed from conjugated and covalently bonded linear polymers.6 Generally 
polymers are synthesized by a process called polymerization, where several types of 
polymerization methods are applied today. In a polymerization reaction, the monomers used 
should have a functional group that enables bond formation. Homo-polymerization and 
copolymerization are the two most common practiced polymerization methods. In homo-
polymerization, one type of monomer is linked together, while in copolymerization two or more 
distinct types of monomers are used.  
Based on the sequential arrangement of the monomers several types of copolymers can be 
synthesized including block copolymers, graft copolymers and random copolymers.7 Natural and 
synthetic polymers are a necessity in our daily life. Growing biomedical applications of polymers 
continue to be discovered and researched from time to time. It has been more than half a century 
that drugs conjugated with polymers have been applied in biomedical fields for therapeutic 
applications. As part of the therapeutic applications of polymers, polycarbonates are developed, 
and their application is being studied. The mechanism of action is similar to the antimicrobial HDP  
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through disrupting the microbial membrane by the interaction of the cationic hydrophilic unit with 
the negatively charged membranes.8,9 
2.3 Statement of purpose of our work 
In our lab, previous group members designed and synthesized amphiphilic polycarbonate 
polymers which have primary amino groups. According to their findings, the polymers exhibited 
potent antimicrobial activity and selectivity against gram-positive bacteria, including multidrug 
resistant strains. Encouraged by the promising results obtained, we have planned certain 
modifications in the composition of the monomers that may lead to the development of new 
polymers which could potentially display broad spectrum antibacterial activity. Phenylalanine, 
lysine and 4-Bromo benzoic acid were used as components of the backbone of 5-methyl-2-oxo-
1,3-dioxane-5-carbonyl chloride (MDC)  and polymerization of the monomers was done 
following the ring opening polymerization mechanism (ROP) as reported by Yang and Hedrick 
et al.10  Lysine derived carbonate monomer was designated to afford the hydrophilic feature of 
the polymer as it has a free primary amino groups, and both phenylalanine and 4- Bromo benzoic 
acid derived monomers will offer hydrophobic characteristics to the polymer.11,10 
2.4 Experimental: Materials and Methods  
2.4.1 Synthesis of Monomer 1 (M1) (Figure 2.1) 
To synthesize Monomer 1, First Di-tert-butyl (6-((2-hydroxyethyl)amino)-6-oxohexane-
1,5-diyl) (S)-dicarbamate was prepared by dissolving 1 equiv N2,N6-bis(tert-butoxycarbonyl)-L-
lysine and 1.5 equiv ethanolamine in Dimethylformamide (DMF), to this solution 1.5 equiv 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), 1.5 equiv 
Hydroxybenzotriazole (HOBT) coupling agents were added  with a 1.5 equiv N,N-
Diisopropylethylamine (DIPEA) base. The mixture stirred for 6 h and after the reaction was 
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completed, work up was done using ethyl acetate and the organic layer was washed with 1N HCl 
(100 mL×3) and brine (50 mL×1). Then product was dried with sodium sulfate and the solvent 
was removed with a rotavapor and it was purified using flash chromatography and we got 80% 
yield. As part of the monomer constituent, 5-methyl-2-oxo-1,3-dioxane-5-carbonyl chloride 
(MDC) was also synthesized following the procedures given by Yang and Hedrick.10 Lastly 
Monomer 1 was synthesized by dissolving 1.5 equiv MDC and 1 equiv di-tert-butyl (6-((2-
hydroxyethyl)amino)-6-oxohexane-1,5-diyl)(S)-dicarbamate in 30 mL Dichloromethane (DCM) 
in a 100 mL round bottom flask, to which 1.5 equiv triethylamine (TEA) base was added. The 
reaction was left for 4 h in an ice bath and then the product was extracted by DCM and was washed 
with 1 N HCl (100 mL×3), brine (50 mL×1) and then dried over sodium sulfate. The solvent was 
removed in vacuo to give oily product, which was further purified by flash chromatography (ethyl 
acetate: hexane 1:1) to give the final white sticky solid product. 
 
Figure 2.1 Synthesis of the Monomer 1. 
 
2.4.2 Synthesis of Monomer 2 (M2) - (Figure 2.2) 
To synthesize Monomer 2, first tert-butyl (S)-(1-((2-hydroxyethyl) amino)-1-oxo-3-
phenylpropan-2-yl) carbamate was prepared by dissolving 1 equiv tert-butoxycarbonyl-L-
phenylalanine and 1.5 equiv Ethanolamine in DMF with coupling agents 1.5 equiv EDC, 1.5 equiv 
HOBT and 1.5 equiv DIPEA base. The reaction was left for 6 h, after the reaction was completed 
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work up was done by ethyl acetate and the product was washed with 1N HCl (100 mL×3) and 
Brine (50 mL×1). The organic solvent was then dried with sodium sulfate and removed by 
rotavapor to get white solid product. From that Monomer 2, was prepared by the adding the above 
product (1 equiv tert-butyl (S)-(1-((2-hydroxyethyl)amino)-1-oxo-3-phenylpropan-2-yl) 
carbamate)  with 1.5 equiv MDC which is synthesized according to Yang and Hedrick,10 and the 
mixture was dissolved in 30 mL DCM with 1.5equiv TEA in a 100 mL round bottom flask. The 
reaction was left for 4 h in an ice bath and then the product was extracted by DCM and was washed 
with 1 N HCl (100 mL×3), brine (50 mL×1) and then dried over sodium sulfate. The solvent was 
removed by rotavapor to give solid product, which was further purified by flash chromatography. 
 
Figure 2.2 Synthesis of the Monomer 2. 
 
2.4.3 Synthesis of Monomer 3 (M3) - (Figure 2.3) 
First 4-bromo-N-(2-hydroxyethyl) benzamide was prepared by dissolving 1 equiv 4-
bromobenzoic acid and 1.5 equiv Ethanolamine in DMF with coupling agents, 1.5 equiv EDC, 1.5 
equiv HOBT and 1.5 equiv DIPEA base. The reaction was left for 6 h, after the reaction was completed 
work up was done by ethyl acetate and the product was washed with 1N HCl (100 mL×3) and Brine 
(50 mL×1). Then the organic solvent was dried with sodium sulfate and vacuo to give a yellowish 
solid product. From that Monomer 3 was synthesized by dissolving 1equiv 4-bromo-N-(2-
hydroxyethyl) benzamide, 1.5 equiv MDC and 1.5 equiv TEA in 30 mL DCM in a 100mL round 
10 
 
bottom flask. The reaction was completed left for 4 h and then the product was extracted by DCM and 
was washed with 1 N HCl (100 mL×3), brine (50 mL×1) and then dried over sodium sulfate. The 
solvent was removed in vacuo to give solid product, which was further purified by flash 
chromatography.  
 
 
Figure 2.3 Synthesis of the Monomer 3. 
 
2.4.4 Synthesis of Polycarbonate Copolymers 
2.4.4.1 Random copolymerization of M1 and M2 (Figure 2.4) 
Batches of polymers were synthesized from M1 and M2 monomers (Table 2.1). All polymers 
were synthesized via ring opening polymerization (ROP) method. The detailed synthesis of random 
copolymer MG-P7 will be given as an example and all further polymers will follow the reaction steps 
and conditions. First 1 equiv initiator benzyl alcohol was dissolved in 10 mL of DCM in a round 
bottom flask after purging with nitrogen gas. Then the two monomers, 30 equiv M1 (hydrophilic 
monomer) and 20 equiv M2 (hydrophobic monomer) were added to the flask together, to this mixture 
1 equiv (3,5-bis(trifluoromethyl)-phenyl)-3-cyclohexyl-2-thiourea catalyst (TU) and 1 equiv 1,8-
diazabicyclo [5.4.0] undec-7-ene (DBU) base were added. The reaction was left stirring for 6 h, and 
then 1.3 equiv benzoic acid was added to quench the reaction. The polymers were then purified by 
dialysis against methanol and distilled water for 3 days using dialysis tubing MWCO 3500 with 
methanol and water being replaced twice a day. The polymer solvent was then vacuumed and then the 
polymers were treated with 15 ml of a 1:1 TFA:DCM mixture for 3 h to deprotect the Boc protecting 
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group in order to obtain the free amine functional groups.12 Again, the polymers were purified in a 
dialyzing tube against methanol and water for 4 days and then freeze dried to get the final product and 
the product was characterized by 1HNMR (Figure 2.5).13 As such, a series of polycarbonate polymers 
containing varying numbers of hydrophobic and hydrophilic groups were prepared in the same manner 
(Table 2.1).  
 
  
Figure 2.4 Synthesis of Random Amphiphilic Polycarbonates. 
 
 
Figure 2.5 1HNMR of Polymer MG-P7 
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Table 2.1 Copolymers synthesized from M 1 and M 2 monomers.  
Compound 
 
Type of Co-
Polymer 
 
 
Hydrophilic Units 
M1 
 
 
Hydrophobic units: 
M2 
 
 
Ideal Molecular 
Weight 
MG-P1 Random 10 30 13932.96 
MG-P2 Random 15 25 13837.95 
MG-P3 Random 15 30 15589.81 
MG-P4 Random 20 25 15494.80 
MG-P5 Random 20 40 20750.36 
MG-P6 Random 30 10 13552.92 
MG-P7 Random 30 20 17056.63 
MG-P8 Random 30 30 20560.34 
MG-P9 Random 20 20 14459.48 
 
2.4.4.2 Random copolymerization of M1 and M3 (Figure 2.6) 
Polymer MG-P9 was prepared in similar fashion as above procedure, but the hydrophobic 
monomer M3 was used instead of M2.  
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Figure 2.6 Synthesis of MG-P9 amphiphilic polycarbonate. 
2.4.5 Antimicrobial Assay 
Minimum Inhibitory Concentration (MIC) of the polycarbonate polymers was determined 
using a broth micro dilution method in 96-well plates against Methicillin-resistant S. aureus (MRSA, 
ATCC 33591), Clostridium difficile (C. diff UK6) and Gram-Negative bacteria E. coli (ATCC 25922). 
Bacterial cells were grown overnight at 37 °C in 4 mL TSB. Approximately 106 CFU/mL bacterial 
suspension in TSB was prepared. Aliquots of 50 µL bacterial suspension were added to 50 µL of the 
polycarbonate polymers to prepare serial diluted concentrations (50 to 0.25 µg/mL) in each well. The 
plates were then incubated at 37 °C for 20h. Optical density (OD) at 600 nm was measured after 18h 
using Biotek microplate reader and the MIC was determined accordingly.14 
2.4.6 MTT Assay 
The cytotoxicity of the polymers was determined by a cell viability assay called MTT assay. 
MTT is a tetrazolium salt which is very soluble in water and turns to an insoluble purple formazan 
through the cleavage of the tetrazolium ring by the dehydrogenase enzyme once it is inserted into the 
cell. Formazan will be accumulated in the cell as it becomes impermeable through the cell 
membrane.15,16 MTT is expressed in terms of IC50 ,which is defined as the concentration of a drug that 
inhibits the growth of 50% of the viable body cells. In this assay, an MTT (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide) reagent was used. To determine the IC50 of the synthesized 
polymers, first 100μL of HepG-2 (human liver carcinoma cells) and HEK-293T (Human embryonic 
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kidney cells) cells with a consistent density (5,000-10,000 cells per well) were added to the well plates 
and incubated overnight. And different polymer concentrations ranging from 128 μg/mL to 0.125 
μg/mL were prepared and added to the cell culture medium and incubated for 16-48h. MTT solution 
was prepared by dissolving MTT in PBS, and then 10μl of the MTT stock solution was added to each 
well and allowed to incubate for 4 h at 37 °C. Solubilizing of formazan was done by carefully removing 
the media from each well without disturbing the cells and 100μl of DMSO was added to each well 
with continuous mixing by pipetting up and down. After incubating the mixture at 37°C for 15 
minutes, absorbance was measured at 540 nm immediately.17 
2.5 Results and Discussion 
Recently, the synthesis of polycarbonate polymers from monomers with primary amino groups 
using benzyl alcohol initiators through ring-opening polymerization (ROP) of MDC was reported as 
an effective way of synthesizing polycarbonate polymers in our lab.12,10 These polymers, containing 
primary amino groups with appropriate hydrophobic group showed optimal amphiphilicity and were 
found to be potent and highly selective antimicrobial polymers, but they were only active against 
gram-negative bacteria.12 To extend this work, we sought to make a change in the previously used 
monomers by some other peptide scaffolds as peptides are potential biological molecules that can be 
modified and mimic the antimicrobial mechanism of natural host defense peptides. Studies revealed 
that cationic peptide Epsilon-poly-L-lysine has antimicrobial activity and is used as a food 
preservative.18 Considering the application of lysine as an antibacterial residue, we designed our 
monomer where lysine could be a main chain and linked to MDC backbone by ethanolamine  to 
produce hydrophilic M1 monomer. Hydrophobic groups are necessary for a polymer to produce 
antimicrobial effect, so we selected another peptide with hydrophobic characteristics to be 
incorporated in to the MDC backbone to make M2 monomer. Phenylalanine was used  to synthesize 
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the hydrophobic monomer as it has been proven for its  antibacterial applications mixed with cationic 
peptides.19 Furthermore, to see the effect of non-peptide hydrophobic residue, 4-bromobenzoic acid 
was used in synthesizing another hydrophobic monomer which is  M3. This monomer was selected 
because many antimicrobial analogs with halogen group in their structures like chlorine, fluorine and 
bromine have been discovered as potent antibacterial residues and we decided to take advantage of 
those groups.20  
The synthesis of the polymers was direct and straight forward. Copolymerization was done 
through ROP following the published protocols given by Yang and Hedrick et al.10 Compared to 
diblock copolymers random copolymers have proven potent antimicrobial activity according to the 
previous study done in our lab.12 As Random core structure ease the interaction of the polymer with 
the membrane of the bacteria via the cationic and hydrophobic interactions,21we decided to focus our 
synthesis mainly on random copolymers. 
Amphiphilicity is the most crucial factor to determine antimicrobial potency of a polymer. To 
see the effect, we synthesized nine polymers by intermixing M1 and M2 monomers as well as M1 and 
M3 monomers (Table 2.1). The synthetic strategy employed to make random copolymers is shown in 
Fig 2.4 and Fig 2.6. To explore our proposal, the polymers were tested against clinically relevant 
threatening strains of Gram-positive bacteria Methicillin-resistant Staphylococcus aureus (MRSA, 
ATCC 33591), and a Gram-negative bacteria Escherichia coli (E. coli, ATCC 25922) for their 
antimicrobial activity (Table 2.2).  
As shown in Table 2.2, Polymers MG-P1:MG-P8 showed similar antimicrobial activity 
against MRSA at 3µg/mL except for MG-P4 which does not show any activity. Polymer MG-P4 had 
almost equal ratios of hydrophilic and hydrophobic residues 20 equiv and 25 equiv respectively. The 
remaining seven polymers had unequal ratios of the residue and showed moderate antibacterial activity 
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against MRSA. The obtained data reveals that the cationic group in the polymer is vital for the 
interaction of the polymers with the negatively charged membrane of the bacterial cell. Though this 
aids in the activity of cell death, the component of hydrophobicity is necessary for the eradication of 
bacterial cells.22 Furthermore, in order to study more about the importance of hydrophobic residue in 
a polymer we synthesized polymer MG-P9 from M1 and M3 monomers where M3 is non-peptide 
analog with bromophenyl group in its structure. We hypothesized the activity of the polymers will  be 
enhanced, as halogen encompassing analogs have already been proven to have potent antibacterial 
activities.22 To synthesize polymer MG-P9, the same type of hydrophilic monomer M1 was used and 
a new hydrophobic monomer M3 was used instead of M2. MG-P9 had 20 equiv hydrophobic and 20 
equiv hydrophilic residues. As expected, the obtained MIC result was encouraging, and it was 0.75 µg 
/mL. This value clearly reveals the presence of halogens in the hydrophobic residue increases the 
hydrophobicity and ensures potent antimicrobial activity. Unfortunately, the desired activity against 
gram negative bacteria was not obtained.  
To further confirm the antimicrobial application of the polymers, we tested the polymers 
against other gram-positive C. diff UK6 bacteria and the result obtained by all polymers was 
encouraging. As shown in Table 2.2, polymers MG-P1, MG-P4, MG-P7 and MG-P9 were found to 
be the most potent polymers against C. diff bacteria as their MIC result is below 1µg /mL. Polymer 
MG-P4, which showed no activity against MRSA, displayed potent activity towards C. diff UK6 at 
0.25 µg /mL. Similarly, polymer MG-P9 showed potent activity of 0.25 µg /mL, as we expected. From 
the MIC results of all the polymers and especially that of polymer MG-P9, we can suggest that the 
presence of halogens, especially bromine, has a significant role in the antimicrobial potency.  
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Table 2.2 Antibacterial activity of polycarbonate Polymers. 
Compound 
Hydrophilic 
   units 
 
  Hydrophobic 
    units 
 
  MIC- Gram Positive bacteria 
          (µg/mL)  
          MTT 
       (IC50) (µg/mL) 
    MRSA  C.diff UK6 HepG-2 HEK-293T 
MG-P1 10 30 6-3 0.5 54.74 49.01 
MG-P2 15 25 6-3 4 - - 
MG-P3 15 30 
6-3 4 - - 
MG-P4 20  25 
NA 0.25 47.13 74.19 
MG-P5 20 40 
6-3 2 - - 
MG-P6 30 10 
6-3 1 65.98 75.15 
MG-P7 30 20 
             < 3 0.5 129.8 126.1 
MG-P8 30 30 
6-3 2 - - 
MG-P9 20 20 
0.75 0.25 86.26 82.5 
 
The cytotoxic activity of the polymers was also analyzed by an MTT assay against HepG-
2 (human liver carcinoma cells) and HEK-293T (Human embryonic kidney cells).  The obtained 
results reveal that the most potent polymers, (MG-P1, MG-P4, MG-P6, MG-P7 and MG-P9) 
which had MIC less than 1μg/mL against C. diff UK6, showed better selectivity. Notably, Polymer 
MG-P9 had IC50 of 86.26 μg/mL and 82.5 μg/mL against HepG-2 and HEK-293T respectively 
which is > 300-fold of selectivity for C. diff UK6 (Figure 2.7). Similarly, polymer MG-P7 had an 
IC50 of 129.8 μg/mL and 126.1 μg/mL against HepG-2 and HEK-293T respectively (Figure 2.8) 
which is > 300-fold of selectivity for C. diff UK6. The results from the MTT assay confirmed that 
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the polymers were highly selective towards bacteria and we decided to do further animal study for 
polymers MG-P9 and MG-P7 to research their cytotoxic property in animals.  
 
Figure 2.7 IC50 of Polymer MG-P9 against HepG-2 and HEK-293T cell lines. 
 
   Figure 2.8. IC50 of Polymer MG-P7 against HepG-2 and HEK-293T cell lines. 
2.6 Conclusion 
To summarize, we have developed a series of polycarbonate antimicrobial polymers based on 
ring opening polymerization method. These polymers display good potency against multidrug-
resistant Gram-positive bacteria.  Both peptide and nonpeptide analogues were used as hydrophilic 
and hydrophobic monomers to synthesize the polycarbonate polymers. The intermixed polymer from 
lysine derived hydrophilic monomer and nonpeptide bromophenyl derived hydrophobic monomer 
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showed the most potent activity towards gram – positive bacteria and the polymer from peptide derived 
lysine and phenyl alanine monomers showed the highest selectivity. Two polymers are being selected 
for further in vivo study and the study is currently ongoing.  
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CHAPTER 3: LIPIDATED DENDRIMERS AS POTENT AND BROAD SPECTRUM 
ANTIBACTERIAL AGENTS 
 
3.1 Introduction 
The resistance developed by bacteria against conventional antibiotics have contributed to 
the sharp rise in illness and deaths caused by bacterial infections that were once curable.1 
Conventional antibiotics are generally small molecules that exert their activity by targeting specific 
cellular nucleic acids and proteins, or cell wall enzymes of bacteria. Bacteria are likely to develop 
mutations rapidly on the targets upon prolonged antibiotic treatment, leading to the development 
of drug resistant bacterial strains.1 In order to combat the emerging resistance, research efforts 
have been focused on developing host-defense peptides (HDPs) as bacteria are believed to have 
less probability to develop resistance to HDPs due to their distinct antimicrobial mechanisms.2 
 It is known that HDPs are naturally occurring peptides that are rich in cationic and 
hydrophobic residues. Despite the diversity in three-dimensional structures, upon association with 
the bacterial membranes, HDPs generally obtain globally amphipathic structures which are critical 
for membrane action on bacteria.3 The interaction  occurs considerably selectively for bacteria as 
the outer leaflet of membranes of bacteria is predominantly rich in negatively charged 
phospholipids.4 In addition, in Gram-positive bacteria, teichoic acids or lipo-teichoic acids are 
frequently identified on the peptidoglycan layer, whereas lipopolysaccharides are common 
components on the outer membranes of Gram-negative bacteria.5 These negative charges greatly 
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contribute to the initial attraction of the catatonically charged HDPs onto the bacterial membranes. 
Subsequently, the hydrophobic patches of HDPs help to penetrate the bacterial membranes through 
hydrophobic interactions with phospholipids. In contrast, the outer surface of mammalian cell 
membranes is largely zwitterionic as they are dominated by neutral phospholipids such as 
cholesterol, phosphatidylcholine, and sphingomyelin, whereas their negatively charged 
phospholipids are essentially located in the inner leaflet of membranes. As such, HDPs have less 
probability to interact with mammalian cells compared with bacteria, which is believed to account 
for at least a significant part of the selectivity of HDPs.6  Since membrane action lacks specific 
molecular targets, it is generally believed that HDPs are less prone to development of antibiotic 
resistance.7 
Owing to the abovementioned advantages, HDPs have received notable attention as a new 
generation of antimicrobial agents combating antibiotic resistance. However, there are noticeable 
limitations associated with HDPs, including low-to-moderate activity, potential high cost of 
manufacturing, susceptibility to proteolytic degradation etc.8 It is conceivable that the 
antimicrobial agents which can mimic the mechanism of HDPs but with enhanced selectivity and 
antimicrobial activity will be one viable strategy for antibiotic development to combat resistance.  
To date, unnatural peptidomimetics such as β-peptides,9 peptoids,10a-10b oligoureas,11 
AApeptides,12a-12f  have been developed to mimic HDPs and target a wide range of bacterial strains. 
These peptidomimetics are generally more active and more metabolically stable than natural 
HDPs, however, they still suffer from potentially high manufacturing cost and difficulty in scale-
up.13 Another alternative approach is to develop cationic antimicrobial polymers including poly 
(α-amino acid)s,14 nylon-3 polymers,15 polyacrylates,16,17 polycarbonates,18 and dendrimers such 
as PAMAM,19 poly(propylene imine),20 etc. Herein we are exploring to design and synthesize 
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efficient and cost effective lipidated poly lysine dendrimer which has biomedical applications 
especially as antibacterial agent.  
3.2 Dendrimer Overview 
Dendrimers are highly branched globular structures consisting of a central core from which 
identical fragments are built up to make star-like macromolecular structures.21 Compared with 
linear polymers, dendrimers are normally in the nano size scale and have narrow polydispersity, 
uniform nanomorphology, and tunable surface entities.22 The terminal groups of the arms of the 
dendrimer determine its solubility and reactivity,21 as well as capability for further modification. 
Dendrimers have attracted significant interest in potential application in the biomedical and 
materials sciences.23 For instance, they have been widely studied in targeted drug delivery systems 
for the treatment of cancer,24 as antimicrobial agents,25 enzyme catalysis and surface engineering 
techniques.26  
Indeed, different attempts have been made to synthesize dendrimer compounds by 
introducing functional groups pertaining to antimicrobial activity, e. g., poly(amidoamine) 
dendrimers with quaternary ammonium salts.27 Lysine dendrimers were synthesized by coupling 
with other peptides and confer activity against bacteria.28 Herein, we are presenting a new class of 
lipidated dendrimers that encompass lysine amino acids to present a multicharged cationic surface 
and bear a hydrophobic domain which is composed of different lengths of lipid tails. We also 
evaluated the dendrimers for their antibacterial activity and mechanism of action.  Intriguingly, 
these dendrimers showed potent and broad-spectrum activity against both Gram-positive and 
Gram-negative bacteria, including multidrug-resistant strains, in addition, the simple design of the 
dendrimers allows easy scale-up and optimization using the solid phase peptide synthesis.29  
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3.3 Result and Discussion  
3.3.1 Solid phase Synthesis of lipidated dendrimers 
Lipidated dendrimers with one lipid tail were initially synthesized on Rink amide resin 
following the standard Fmoc chemistry protocol used for the solid phase peptide synthesis. Briefly, 
20% piperidine in DMF was used to remove the Fmoc protecting group in every coupling cycle 
which was followed by the coupling of 2 equiv of the desired amino acid, 4 equiv of HOBT (1-
hydroxybenzotriazole monohydrate) and DIC (diisopropylcarbodiimide) in DMF for 4 h.30 The 
coupling reaction time was prolonged to 6-8h upon increasing the number of generations of the 
dendrimers. In order to introduce hydrophobic lipid tails, initially 4-Methyltrityl-Lys(Fmoc)-OH 
was attached onto the rink amide resin. Then the 4-Methyltrityl protecting group was selectively 
removed under 2% TFA. The lipid tail was attached, followed by coupling of the Fmoc-
Lys(Fmoc)-OH monomer (Scheme 1) until the desired dendrimers were obtained. The lipidated 
dendrimers were cleaved from the solid support and purified by HPLC and then tested for their 
antimicrobial activity against a panel of Gram-positive and Gram-negative bacteria (Table 2.1), 
including three clinically threatening Gram-positive bacterial strains, methicillin-resistant S. 
epidermidis (MRSE, RP62A), vancomycin-resistant E. faecalis (VREF, ATCC 700802), and 
methicillin-resistant S. aureus (MRSA, ATCC 33591), and two Gram-negative bacterial strains, 
E. coli (ATCC 25922), P. aeruginosa (ATCC 27853).  
3.3.2 Antimicrobial and Hemolytic activity 
As shown in Figure 3.1 and Table 3.1, the dendrimer D-A-1 which has only two positively 
charged amino groups and one C16 tail already exhibited good antibacterial activity against Gram-
positive bacterial strains, with MICs of 3 µg/mL against MRSA and Enterococcus faecalis and 1.5 
µg/mL against MRSE bacterial strains, respectively. Encouraged by the positive results, we 
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synthesized D-A-2 which bears twice the cationic groups and the same hydrophobic tail as D-A-
1. To our delight, the dendrimer exhibited potent and broad-spectrum activity against both Gram-
positive and Gram-negative bacterial strains with activity of 0.75 µg/mL against Gram-positive 
strains and 3 µg/mL against Gram-negative strains. It is exciting that this dendrimer is highly 
selective for bacteria because it only has very limited hemolytic activity (Table 3.1). 
 
Figure 3.1 Solid phase Synthesis of D-A dendrimers. 
To further understand the structure function relationship of this type of dendrimers in terms 
of cationic charges, D-A-3 and D-A-4 were synthesized by increasing the terminal cationic amine 
groups to 8 and 16, whereas the C16 hydrophobic tail was retained. Interestingly, bearing double 
cationic charges, the activity of D-A-3 slightly reduced against all bacterial strains when compared 
to D-A-2. D-A-4, containing 16 cationic charges, was found to be inactive against both Gram-
positive and Gram-negative bacterial strains. The results suggested that cationic charges by 
themselves are not solely responsible for antimicrobial activity; optimized cationic charges and 
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hydrophobicity are necessary for both antibacterial activity and selectivity. Bearing balanced 
cationic groups and hydrophobic tail, we hypothesized D-A-2 was able to selectively bind to 
negatively charged bacterial membranes and insert its lipid tail into bacterial lipid layers. However, 
with more cationic amino groups on the dendrimers, the hydrophobic tail was shielded in their 
core, reducing its hydrophobic interactions with bacterial lipids, leading weaker or even abolished 
capability to disrupt bacterial membranes.  
Table 3. 1 The Antibacterial and Hemolytic Activity of Lipidated Dendrimers. 
 
Next, we set out to evaluate the impact of hydrophobicity of the dendrimers on the 
antimicrobial activity by synthesizing a series of dendrimers (D-A-2a to D-A-2d) which have the 
same cationic charges as the most active dendrimer D-A-2 but varying hydrophobicity due to the 
change in the length of the lipid tail. As shown in Figure 3.1 and Table 3.1, D-A-2a, D-A-2b, D-
A-2c, D-A-2d had a C14, C12, C10, C8 lipid tail, respectively. Interestingly, compared to D-A-2, 
the dendrimers D-A-2a, D-A-2b exhibited reduced activity against Gram-positive bacteria, 
whereas they lost activity against Gram-negative bacteria at the tested conditions.  Furthermore, 
 
 
Dendrimer 
 
 
MW 
 
Number  
of positive 
charges 
Length  
of 
lipid tail  
        Gram-positive 
        bacteria (µg/mL) 
 
Gram-negative 
bacteria (µg/mL) 
 
Hemolysis 
 
 (HC50 µg/mL) 
 
 
 
Selectivity 
indexof MRSA 
(HC50/ MIC) 
MRSA MRSE VREF E. coli P. A 
D-A-1 511.80 2 16 3.0 1.5 3.0 >25 >25 125 42 
D-A-2 768.15 4 16 0.75 0.75 0.75 3.0 3.0 >250 >333 
D-A-3 1280.85 8 16 1.5 1.5 1.5 6.0 6.0 >250 >166 
D-A-4 2306.25 16 16 >25 >25 >25 >25 >25 - - 
D-A-2a 740.09 4 14 1.5 1.5 1.5 >25 >25 125 83 
D-A-2b 712.06 4 12 3.0 1.5 3.0 >25 >25 125 42 
D-A-2c 683.98 4 10 >25 >25 >25 >25 >25 - - 
D-A-2d 655.93 4 8 >25 >25 >25 >25 >25 - - 
D-B-1 878.39 2 
Two C16 
 tails 
>25 >25 >25 >25 >25 - - 
D-B-2 1134.74 4 >25 >25 >25 >25 >25 - - 
D-B-3 1647.44 8 >25 >25 >25 >25 >25 - - 
28 
 
D-A-2c and D-A-2d dendrimers completely abolished their activity (Table 3.1) toward both 
Gram-positive and Gram-negative strains. This is consistent to previous findings,31,32 that C16 
lipid tail is necessary to penetrate bacterial membranes. Ones with short lipid tails have less 
probability to interact and lack capability to penetrate bacterial membranes. 
 
Figure 3.2: Solid phase Synthesis of a series of D-B dendrimers. 
To further evaluate the effect of hydrophobic lipid tails on the activity, we next synthesized 
dendrimers containing two C16 lipid tails based on the most potent compound D-A-2. In order to 
synthesize this type of dendrimer, after removal of the 4-Methyltrityl protecting group, Dde-
Lys(Dde)-OH monomer was coupled on to the first monomer on the solid support (Figure 3.2), 
followed by the deprotection of the Dde group.33,34 Then to each of the two unprotected amines, 
one C16 tail was attached. Their antimicrobial activity was also examined and shown in Table 3.1. 
Interestingly, those sequences, D-B-1, D-B-2 to D-B-3, did not show any activity towards bacteria 
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under the tested conditions. Indeed, the results are consistent to our previous findings,35 and we 
hypothesized that those dendrimers may self-assemble into micelles due to strong hydrophobic 
interaction among each other, which deteriorates their ability to penetrate bacterial membranes. 
3.3.2 Mechanism of Action 
The antimicrobial activity of these dendrimers suggested that both cationic and 
hydrophobic groups are required to be present in balance for the dendrimers to exhibit broad-
spectrum antibacterial activity, a structural motif analogous to that of HDPs. To confirm that these 
dendrimers exhibit antibacterial activity by acting on bacterial membranes, Florescence 
microscopy (FM)36,37,38 and transmission electron microscopy (TEM)6 experiments were 
conducted for Gram-positive strain (MRSA) and a Gram-negative strain (E. coli). In FM assay, 
4′,6-diamidino-2-phenylindole (DAPI) is used as a membrane permeable dye that stains all live 
and dead cells, whereas propidium-iodide (PI) is the non-membrane permeable dye that stains only 
the dead cells. The most active dendrimer D-A-2 was chosen for the study, which revealed its 
ability to disrupt the membrane of MRSA and E. coli, respectively, as PI stain was observed only 
with the bacteria which were treated with D-A-2 but not in the control bacteria (Figure 3.3).  
     
          MRSA                                                                                         E. coli 
Figure 3.3 Fluorescence micrographs of MRSA and E. coli that were treated or not treated with 25 
μg/mL of D-A-2 for 2 h: (C1) control, no treatment, DAPI stained; (C2) control, no treatment, PI 
stained; (D1) treatment with D-A-2, DAPI stained; (D2) treatment with D-A-2, PI stained. 
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To further prove our hypothesis that lipidated dendrimers mimic the mechanism of action 
of HDPs, TEM microscopy images were used to analyze the morphology of the drug treated and 
non-drug treated bacteria. As shown in Figure 3.4 the membranes of both MRSA and E. coli were 
compromised when treated with the dendrimer D-A-2. 
             
Figure 3.4 TEM micrographs of MRSA and E. coli treated with 10 µg/mL of D-A-2 for 2 h: (a) 
control, no treatment; (b) treatment with D-A-2, initial rupture of the bacterial membrane; (c) 
treatment with D-A-2, complete cell rupture leading to bacterial cell death. 
3.3.3 Bacterial Kinetic Study 
To future investigate the time of bactericidal action of the dendrimers, bacterial kinetics 
assay was conducted. The most active dendrimer D-A-2 was investigated and the time required to 
show its bactericidal action was analyzed for Gram-positive and Gram-negative bacteria. Colony 
forming units of the Gram-positive and Gram-negative bacteria on the agar plate were counted for 
three different concentrations (50 µg/mL, 25 µg/mL, 12.5 µg/mL) of the D-A-2 treated bacteria 
and the control bacteria at regular intervals of 10 min, 30 min, 1 h, 2 h. As shown in Figure 3.5, it 
is evident that at the concentration of 50 µg/mL, 25 µg/mL 12.5 µg/mL, the Gram-positive bacteria 
MRSA were eradicated completely after 1 h, whereas the Gram-negative bacteria, E. coli was also 
eradicated after 2 h at the concentration of 50 µg/mL, 25 µg/mL, 12.5 µg/ml. This delay in 
bactericidal action on the Gram-negative bacteria might be due to the presence of the extra outer 
membrane layer, which is not present in the Gram-positive bacterial strains. Overall, the Time kill 
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studies deomonstrated that the dendrimer could rapidly kill bacteria.    
        
 
MRSA       E. coli 
Figure 3.5 Time kill study of D-A-2 against MRSA and E. coli. 
3.3.4 Bacterial Biofilm Assay 
The infections caused by biofilms are a great threat to human life. Recent reports have 
shown that 80% of the bacterial infections are caused due to biofilms.39 Bacterial biofilms have 
become a severe problem specially in the cases of patients who suffer from infections that occur 
from the antibiotic resistant bacteria.40 Biofilms formed by MRSA and E. coli are currently the 
major concern in hospitals as they contaminate the surgical tools and organ catheters.41 Therefore, 
development of new antibiotic agents that act against biofilm formation has become a major 
strategy to treat bacterial infections. We thus analyzed the biofilm inhibiting efficiency of the most 
active dendrimer D-A-2 against MRSA and E. coli. As shown in Figure 3.6, even at 0.17 μg/mL, 
D-A-2 was able to inhibit 85% of biofilm formation of E. coli and was able to completely eradicate 
the biofilm formation of MRSA. At the concentration of 0.8 μg/mL, D-A-2 was able to eradicate 
biofilm formation of E. coli completely. The above stated results confirm that the dendrimers can 
act as biofilm inhibitors. 
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Figure 3.6. Inhibition of biofilms of MRSA and E. coli by D-A-2 
 
3.4 Materials and methods 
3.4.1 Antimicrobial Assay 
Lipidated dendrimers were tested against different strains of bacteria to determine their 
Minimum inhibitory concentration (MIC). Three clinically threatening Gram-positive bacterial 
strains including methicillin-resistant S. epidermidis (MRSE, RP62A), vancomycin-resistant E. 
faecalis (VREF, ATCC 700802), and methicillin-resistant Staphylococcus aureus (MRSA, ATCC 
33591) and two Gram-negative bacterial strains, E. coli (ATCC 25922), P. aeruginosa (ATCC 
27853) were used for testing. A serial dilution method was performed to determine the 
antimicrobial activities. In 4 mL of TSB solution a single colony of bacteria was grown and 
incubated at 37 °C overnight after which the cultured bacteria were diluted by 100-fold and were 
shaken until their mid logarithmic phase was obtained. 50 μL of medium containing different 
concentrations of the lipidated dendrimers was made in each vial of the 96 well plate. 50 μL 
aliquots of bacterial suspension was added to the medium with different drug concentrations. The 
96 well plate was incubated at 37 °C overnight and the cell growth was monitored using Biotek 
synergy HT microtiter plate reader under the 600 nm wavelength absorbance. The assay was 
repeated three times.42,42b,43 
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3.4.2 Hemolysis Assay  
The selectivity of the lipidated dendrimers was determined through hemolysis assay. To 
perform this assay fresh K2EDTA treated human red blood cells (hRBCs) were centrifuged at 
1000g for 10 minutes. The step was done three times until the supernatant was clear, then the 
desired suspended erythrocytes were collected and washed with PBS buffer a couple of times. The 
collected RBCs were then diluted into 5% v/v suspension. From the diluted solution 50 μL was 
taken and added to the already prepared serially- diluted lipidated dendrimer solutions and were 
left for incubation at 37 °C for 1 hr. The incubated solutions were centrifuged at 3500 rpm for 10 
minutes. To measure the absorbance, 30 μL of supernatant was diluted with 100 μL of PBS and 
absorbance at a wavelength of 540 nm was recorded. Selectivity of the lipidated dendrimers (% 
Hemolysis) was then calculated by applying the formula   % hemolysis = (Abs sample − Abs PBS)/ 
(Abs Triton − Abs PBS) × 100%, where PBS was used as a negative control and 0.1% Triton x-
100 was used as a positive control. Results were repeated two times with duplicates each time.44 
3.4.3 Fluorescence Microscopy  
To assess whether the lipidated dendrimers act on the bacterial membrane or not, a double 
staining Florescence microscopy assay was used. Both 6-diamidino-2-phenylindole 
dihydrochloride (DAPI) and propidium iodide (PI) dyes were selected as fluorophores to 
differentiate between the dead bacterial cells and viable cells. DAPI is capable of staining both 
live and dead cells but PI can only stain dead cells due to its impermeable nature through the 
membrane. The bacteria were grown to mid logarithmic phase and were incubated with lipidated 
dendrimers at 37 °C for 2 h, the mixture was centrifuged at 1000g for 10 min. Once the bacterial 
pellets were collected and washed with PBS three to four times. They were subsequently incubated 
with PI (5 μg/mL) in the dark for 15 min at 0 °C, the excessive PI was rinsed using PBS several 
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times. Lastly, the cells were incubated with DAPI (10 μg/mL) for 15 min on ice and the excess 
DAPI was removed by washing with PBS buffer. After the samples were ready 10 μL of the 
bacteria were used for testing under Zeiss Axio Image Zloptical microscope using 100× oil-
immersion objective.44 
3.4.4 Time kill study 
 The kinetic assay of the lipidated dendrimers was tested against MRSA and E. coli. The 
bacteria were grown to midlogarithmic phase in TSB medium and then diluted into 106 CFUmL-1 
suspensions. Different concentrations of the lipidated dendrimers were then added to the diluted 
suspensions and incubated for 10 min, 30 min, 1 h, and 2 h, respectively. After incubation, the 
mixture was diluted into 102 to 104 times, then dispersed on TSB agar plates and incubated 
overnight at 37 °C. The colonies on the plates were counted and graphed against colony forming 
unit of bacteria and incubation time.45  
3.4.5 TEM Study 
Similar procedure was used to grow the bacteria to mid logarithmic phase as in the case of 
MIC study. Two samples were made, one batch has only bacteria and the other batch was the 
bacteria treated with D-A-2. Samples were incubated at 37 °C for 2 h and the solution was 
centrifuged at 1000g for 10 min. Bacterial pellets were collected at the bottom of the tube. Pellets 
were washed with PBS three to four times before dissolving in water to a 10-6 M.32 A drop of the 
solution was added on the carbon-coated Cu grid and the excess sample was wiped off with the 
filter paper to avoid any aggregation. The grid was then left for 30 min on the bench top so that 
the sample can be absorbed onto the grid. The samples on the grids were analyzed and images 
were taken with FEI Morgagni 268D TEM instrument.46,47 
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3.4.6 Biofilm assay 
The bacteria were grown and the treated with the dendrimers in 96 well plate in a similar 
fashion as MIC study. The 96 well plates were left for incubation at 37 °C for 48 hours. The plate 
was shaken over an empty tray to remove all the planktonic bacteria. The 96-well plate was then 
rinsed in a large tray of water and shaken. Rinsing of the plate in water was done a couple of times. 
The plate was placed on the paper towel to get rid of the water from the wells and was laid on 
another paper towel and left to dry overnight. The wells were stained with 125 μL 0.1% crystal 
violet solution for 10 minutes. The plate was shaken over the empty tray to remove the solution 
and the plate was rinsed with water a couple of times until the wells are free of any liquid crystal 
violet and left to dry overnight. 200 μL of 30% acetic acid were added to the wells to solubilize 
the stained crystal violet and left for 10 min. 125 μL of the solution was transferred from each well 
into a flat-bottom 96-well plate. The plate was read at OD 595 nm with a plate reader.43 The 
average of the blank wells was subtracted from the OD of each sample that contained sample and 
the average of the wells with samples were calculated. The averages of the sample wells were 
normalized to the average of the control wells.4 
3.5 Conclusion 
We have developed a new class of antimicrobial lipidated dendrimers that can mimic the 
HDPs. The design was straightforward which allows further development and optimization at ease. 
Our findings suggest that amphiphilicity is required for the dendrimer to display potent and broad- 
spectrum activity against a range of multidrug-resistant Gram-negative and Gram-positive 
bacteria. These lipidated dendrimers were also proven to act as good biofilm inhibitors, further 
augmenting their potential of practical applications. Furthermore, these dendrimers could be 
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developed for other biological applications to treat various fungal, viral infections and their activity 
is yet to be explored. 
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CHAPTER 4: UNIMOLECULAR NANOPARTICLES AS POTENT ANTIMICROBIAL 
AGENTS 
4.1 Introduction 
Antibiotic resistance is emerging to be one of the three greatest threats to global public 
health in the 21st century.1,2 As a result, significant interest has been devoted to the development 
of the new strategies combating drug resistance. Among them, natural cationic host-defense 
peptides (HDPs) are believed to be most promising due to their minimum risk of resistance 
development.3,4 It is known that conventional antibiotics generally target proteins involved in 
bacterial cell wall biosynthesis, or intracellular targets such as nucleic acids.3,5 Such mechanisms 
involving defined targets can frequently lead to mutations in bacteria, thereby inducing significant 
antibiotic resistance.6 However, HDPs have existed universally in vertebrates for thousands of 
years, and they still possess broad-spectrum antibacterial activity. It is intriguing that HDPs have 
diverse three dimensional structures, such as α-helices and β-sheets,3 however they are all rich in 
cationic and hydrophobic residues. The cyclic and linear forms of the HDP are due to the presence 
of disulfide bonds and presence of multiple arginine and lysine amino acids in the sequences. This 
also gives them a basic property and amphiphilic nature.7  
Bacterial cell membranes are composed mainly of proteins and phospholipids. The 
phospholipid layer has a polar hydrophobic glycerol and hydrophobic fatty acid tails which gives 
the amphiphilic nature of the membrane. HDPs directly acts on the bacterial membrane. The 
positively charged nature of HDPs allows its electrostatic interaction with the negatively charged 
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membrane as the glycoprotein present in the membrane is the binding sites for the HDPs.8, 9 HDPs 
are believed to use their hydrophobic domain to penetrate and disrupt membrane lipid layers, 
which subsequently leads to leakage of cellular contents and cell death.7,10 This explains why 
HDPs have diverse three dimensional structures, because this mechanism of membrane disruption 
is based on non-specific biophysical force of hydrophobic and hydrophilic interactions, and 
therefore no defined secondary or tertiary structures are necessary.11  
Although any therapeutic agents would inevitably develop resistance in their targets, 
including cells and organs of the organisms, HDPs may be less prone to the trend because the 
membrane disruption by HDPs is non-specific and HDPs lack defined membrane targets.9 It should 
also be noted that the action of HDPs may also involve other mechanisms, such as targeting 
intracellular and cell wall targets, much as traditional antibiotics do, however, the electrostatic 
interaction and/or disruption of bacterial membranes still generally exist in these HDPs, which are 
critical for their permeation into bacterial cells.8 
One of the successful examples of HDPs is magainin-2,12 which shows moderate 
antimicrobial activity against bacteria. Synthetic peptide analogs such as Pexiganan (also known 
as MSI-78) have shown much improved activity and entered Phase III clinical trials for the 
treatment of diabetic foot ulcers. However, it eventually failed in the clinical trial, largely due to 
its moderate antimicrobial activity and high production cost.13 Furthermore, although the 
selectivity of HDPs is good, it is still not ideal yet, as they display toxicity such as hemolytic 
activity.  
The scientific and clinical expansions in the antibiotic development is to advance agents 
which can mimic the mechanism of HDP and with relatively low bacterial resistance and 
maximum efficacy as well as minimum toxicity. Recently many research studies are launched to 
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develop synthetic peptidomimetics including β-peptides,14-16 peptoids,17 oligoureas,18 
AApeptides.19-23 Though the ongoing development in the area of peptidomimetics is promising, 
the selectivity problem, manufacturing cost and the efficiency of the synthesis method are 
challenging.24-26 
Another innovative approach to developing antimicrobial agents is mimicking the HDPs 
through biodegradable polymers. Like HDPs, they contain both hydrophobic and hydrophilic 
cationic groups in their sequences, which are synthesized by amphiphilic building blocks through 
homo-polymerization, or by both hydrophobic monomers and cationic monomers through block-
by-block or random copolymerization. The antibacterial mechanism of action of polymers is 
similar to that of HDPs. Some polymers function through interaction with bacterial membranes by 
single random sequences,10,27-31 while others are designed to self-assemble into nanoparticles, then 
act on the surface of bacterial membranes.27,32,33 It is suggested that through the formation of 
nanoparticles, there is an increase of local mass and cationic charges on the bacterial surface which 
facilitates disintegration of bacterial membranes.33 However, this limits the mechanism of action 
and activity of self-assembled nanoparticles to be higher than their critical micelle concentration 
(CMC).33 
4.2 Overview of Unimolecular Micelle Hyperbranched Polymers 
Unimolecular micelles are a class of small entities of micelles with a discrete core 
surrounded by shells which are formed by a covalent bond chain. With the current innovations in 
polymer chemistry, unimolecular micelles are functionalized in various architectural designs, 
including amphiphilic dendrimers, amphiphilic star polymers and hyperbranched polymers called 
polymeric micelles.34 Unimolecular micelle hyperbranched polymers are built from a dendrimer 
core where the arms of the core are composed of both hydrophobic and cationic polymers. Bearing 
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special structural and functional properties, biodegradable-unimolecular polymeric micelles are 
becoming imperative candidates for drug delivery applications, encapsulating and solubilizing a 
hydrophobic guest molecule and antimicrobial applications in the biomedical era.35  
The antimicrobial application of the unimolecular micelle is hypothesized to be more 
potent and selective compared with the regular antimicrobial polymers, because of the spatial 
architectural design, which improves their interaction with the bacterial membrane. Each 
unimicelle is acting as a nanoparticle. Such a design is devoid of potential de-assembly of 
assembled nanoparticles under low concentrations, ensuring constant high local mass and cationic 
charges which is crucial for antimicrobial application mechanism. In addition, the hydrophobic 
groups present in the structure may be sequestered in the interior of the micelles, which decreases 
the probability of non-specific interaction of nanoparticles with mammalian cells, thereby 
enhancing the selectivity towards bacteria. Indeed, these unimicelle nanoparticles can also be 
scaled-up to make large quantities, and they are biodegradable, augmenting their potential in vitro 
and in vivo applications.33,35 Herein, we present the design and application of unimolecular micelle 
hyperbranched polymers as antimicrobial agents. 
4.3 Experimental Section 
4.3.1 Synthesis of Hyperbranched Polyester Polyacid (HBPP) (Figure4.1)   
A weighed portion of 1 equiv of Boltorn H311 was heated to 140 OC for 2h under nitrogen 
blowing to break the hydrogen bonds and make it anhydrous. Then it was cooled to 50 OC and 
dissolved in 1,4-dioxane. To the heated solution of the Boltorn H311, a stoichiometric amount 5 
equiv of maleic anhydride to each dendrimer arm (5 equiv*23) and catalytic amount of stannous 
chloride (SnCl2) (1% with respect to the Boltorn weight) were added simultaneously. The mixture 
was stirred at a temperature of 100 OC for 36 h. After cooling, the solvent was removed in vacuo 
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and the product was purified by dialysis against methanol for 2 days and distilled water for 2 days 
using dialysis tubing MWCO 3500 where methanol and water being replaced twice a day.36 The 
product was then freeze dried and characterized by 1HNMR (Figure 4.2).   
 
Figure 4.1 Synthesis of HBPP 
 
Figure 4.2 1H NMR of HBPP 
4.3.2 Synthesis of hydroxyl terminated hyperbranched polyester (Figure 4.3) 
To synthesize hydroxyl terminated hyperbranched polyester, 1 equiv of hyperbranched 
polyester polyacid (HBPP, Figure 4.1) was dissolved in 20 ml DMF and then (5 equiv*23) of 
ethanolamine (2-aminoethan-1-ol), (5 equiv*23) EDC, (2 equiv*23) HOBT and (2 equiv*23) DIPEA 
base were added. The solution mixture was stirred at room temperature overnight.  After the reaction 
was completed, work up was done using 100 ml of ethyl acetate and the product was washed with 1N 
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HCl (100 mL×3) and Brine (50 mL×1). The product was then dried over anhydrous sodium sulfate 
and the solvent was removed in vacuo to give yellowish oily product, it was then purified in a dialysis 
tubing for 4 days using methanol and water.36 The product was then freeze dried and characterized by 
1HNMR (Figure 4.4). 
 
Figure 4.3 Synthesis of hydroxyl terminated hyperbranched polyester 
 
 
Figure 4.4 1H NMR of hydroxyl terminated hyperbranched polyester  
4.3.3 Synthesis of Hydrophilic monomer (M1) (Figure 4.5) 
Monomer 1 (2-((tert-butoxycarbonyl) amino) ethyl 5-methyl-2-oxo-1,3-dioxane-5-
carboxylate) was synthesized following the published paper in our lab by Jianfeng Cai and Alekhya 
Nimmagadda.37  
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Figure 4.5 Monomer 1 (M1) synthesis. 
4.3.4 Synthesis of Hydrophobic monomer (M2) (Figure 4.6) 
Monomer 2 was prepared according to the previously reported protocol by Yang and 
Hedrick.38
Figure 4.6 Monomer 2 (M2) synthesis 
4.3.5 Synthesis of Unimolecular micelle hyperbranched polymers (Figure 4.7 & Figure 4.8) 
We propose to synthesize both random and diblock unimolecular micelles hyperbranched 
polymers (Figure 4.7 & Figure 4.8). As shown in Figure 4.5 & Figure 4.6 first both hydrophilic and 
hydrophobic monomers were synthesized  following the protocols reported in the published paper of 
our lab and a paper from Yang and Hedrick et al.37,38 Hyperbranched polymers were then synthesized 
through ring-opening polymerization in the presence of the two complementary monomers and the 
unimolecular micelle core.39 To synthesize random unimicelle polycarbonate P6, 1 equiv of hydroxyl 
terminated hyperbranched polyesters as a macro initiator and 20 equiv of hydrophilic monomer (M1) 
and 20 equiv of hydrophobic monomer (M2) were mixed together and dissolved in 10ml of anhydrous 
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DCM in a N2 purged round bottom flask. To this mixture 1 equiv of 1,8-diazabicyclo undec-7-ene 
(DBU) and 1 equiv of 1-(3,5-bis(trifluoromethyl)-phenyl)-3-cyclohexyl-2- thiourea (TU) catalyst 
were added and the reaction was left overnight and the next day the reaction was quenched by 1.1 
equiv of benzoic acid and purification of the polymer was done by dialyzing against methanol in a 
MWCO 3500 dialysis tubing for 3 days, after that the polymers were then treated with 15 ml of a 1:1 
TFA:DCM mixture for 3 h to deprotect the Boc protecting group in order to obtain the free amine 
functional groups. And then the polymer was purified again in a dialysis tubing (MWCO 3500) for 2 
days in methanol and 2 days in water and it was then freeze dried and a brownish semisolid product 
was attained. As such, a series of hyperbranched polymers containing varying numbers of hydrophobic 
and hydrophilic groups were prepared in the same manner (Table 4.1). 
 
     
  Figure 4.7 Synthesis of unimolecular nanoparticles with random chains of polycarbonates. 
Similarly, Di-block hyperbranched polycarbonate armed unimicelle polymers (Table 4.1) 
were synthesized in the same way as the random block polymers. However, the two monomers were 
added in two batches, first monomer 1 was added along with the macro initiator, TU catalyst and DBU 
base and the reaction runs for 6 h and then monomer 2 was added and the reaction was left for 
polymerization for 6 h (Figure 4.8).37 
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Figure 4.8 Synthesis of unimolecular nanoparticles with diblock chains of polycarbonates.  
Table 4.1 Unimolecular micelle hyperbranched polymers. 
 
Compound 
               Type of 
      Unimicelle polymer 
 
Hydrophobic arms 
 
Hydrophilic arms 
P1 
Di-block 10 10 
P2 
Random 10 10 
P3 
Di-block 
15 15 
P4 
Random 
15 15 
P5 
Di-block 
20 20 
P6 
Random 
20 20 
P7 
Di-block 
25 25 
P8 
Random 
25 25 
P9 
Di-block 
30 30 
P10 
Random 
30 30 
P11 
Di-block 
40 40 
P12 
Random 
40 40 
 
4.3.6 Antimicrobial Assay 
Antimicrobial assay of the synthesized unimicelle polymers was carried out following similar 
protocols as reported in the published papers of our lab.40, 41Two clinically relevant bacterial strains, 
Gram-positive Methicillin-resistant Staphylococcus aureus (MRSA, ATCC 33591) and Gram-
negative E. coli (ATCC 25922) bacteria were used to perform the MIC assay. The minimum inhibitory 
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concentration (MIC) is the lowest concentration that completely inhibits the growth of bacteria in 20 
h. The MIC was made in sterile 96 well plate, first a single colony of bacteria was isolated and allowed 
to grow in 4 ml TSb solution for 12 h at 37 °C in a shaking incubator. Next day the grown culture was 
diluted by 100-fold and was shaken for 6 h to attain mild-logarithm phase. To the 96-wellplate 50 µL 
of the unimicelle polymer solution in 2-fold serial dilution of TSB were added, then 50 µL diluted 
bacterial in TSB medium (1 × 106 CFU/mL) was added to each well. The well-plate was incubated for 
20 h at 37 °C and MIC was determined from the Biotek Synergy HT microtiter plate reader absorption 
at 600 nm wavelength. 
4.4 Results and Discussion 
           Dendritic polymers, including HBPs in which polar amines, hydroxyl or amide groups 
presented in their terminal ends were found to be a highly selective and potent antimicrobial 
compounds in addition to the straight forward synthesis method and high yield production.42 We are 
here presenting a contemporary design of unimolecular micelle hyperbranched polymers by 
incorporating polycarbonate monomers in the arms of a dendrimer core (Boltorn™ H311) to function 
as antimicrobial agents in biomedical era. We chose polycarbonates to be incorporated in the arms of 
unimolecular micelle as polycarbonates are biocompatible, biodegradable, and can be polymerized 
easily through ring-opening polymerization (ROP). Moreover, Yang and Hedrick et al have already 
demonstrated the polycarbonates potential for antimicrobial applications.38  
              Polyol Boltorn™ (aliphatic hyperbranched polyester) are dendritic polymers which have a 
highly branched flexible backbone that can embrace more than 20 terminal hydroxyl groups. In our 
study, Boltorn™ H311 (MW 5300 g/mole) which has 23 terminal hydroxyl branches of functional 
groups was used for the synthesis of the unimolecular nanoparticle as it can be adapted easily to 
dendrimers as well as unimicelles.43,44   As per our design the polycarbonate monomers have to be 
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complexed to the arms of the Boltorn, so first the hydroxyl terminal of the Boltran has to be lengthened. 
To achieve this approach then, first the hydroxyl terminal of Boltran was transformed into carboxyl 
terminal to attain a high reactivity for the next reactions by reacting the Boltran H311-OH with maleic 
anhydride in the presence of tin(II) chloride in dioxane (Figure 4.1). Once the reactive carboxyl group 
was obtained ethanolamine was coupled to it to produce an elongated hydroxyl terminal arm of Boltorn 
(Figure 4.3).36 
            Polymerization was done through ROP method, and 12 unimolecular micelle hyperbranched 
polymers were synthesized by incorporating the two monomers M1 and M2 in to the arms of the 
hydroxyl terminated hyperbranched polyester H311 macro initiator (Figure 4.7 and Figure 4.8). To 
see the disparity in the antimicrobial activity among the 12 polymers, 6 were diblock polymers and 
the rest were random block polymers (Table 4.1).  
Earlier study in our lab discloses, polycarbonate polymer which has 20 equiv hydrophilic and 
20 equiv hydrophobic monomers with benzyl alcohol initiator was the most potent towards gram 
positive bacteria but were not active against gram negative bacteria.37 Bearing that in our mind we 
hypothesized by manipulating the same polycarbonate polymers in unimolecular micelle core could 
enhance the antibacterial activity of the polymers towards broad spectrum.  
          The antibacterial activity of the synthesized polymers was studied against Gram-positive 
Methicillin-resistant Staphylococcus epidermidis (MRSE, RP62A) and Gram-negative E. coli (ATCC 
25922) bacteria. As the antimicrobial activity is shown in Table 4.2 both diblock and random polymers 
displayed significant antibacterial activity against Gram positive bacteria and to our delight diblock 
polymer P5 and random block polymers P6 and P12 presented broad spectrum activity against both 
gram positive and gram-negative bacteria.  
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Polymers P1and P2 which have the same number of hydrophilic and hydrophobic units (10 
equiv:10 equiv) displayed potent antimicrobial activity (0.75µg /ml) against MRSA but they were not 
active to gram negative bacteria, this could be due to the desired amphiphilicity was not obtained to 
break the extra outer membrane of the gram-negative bacteria. 
Table 4.2 The Antibacterial Activity of Unimolecular micelle hyperbranched polymers. 
Polymer 
    Type of  
   Copolymer 
Hydrophilic 
   units 
 
  Hydrophobic 
    units 
 
    MIC- MRSA 
      (µg/mL) 
MIC- E. coli  
    (µg/mL) 
P1 Di-block 10 10 0.75 NA 
P2 Random 10 10 0.75 NA 
P3 Di-block 15 15 6~12.5 NA 
P4 Random 15 15 3~6 NA 
P5 
Di-block 
20 20 
6~12.5      12.5~25 
P6 
Random 
20 20 
1.5~3      12.5~25 
P7 
Di-block 
25 25 
6~12.5 NA 
P8 
Random 
25 25 
6~12.5 NA 
P9 
Di-block 
30 30 
6~12.5 NA 
P10 
Random 
30 30 
6~12.5 NA 
P11 
Di-block 
40 40 
12.5~25 NA 
P12 
Random 
40 40 
6~12.5       12.5~25 
 
Next, we synthesized a series of  polymers (P3, P4, P5 and P6) by increasing the number of 
equivalents of hydrophilic and hydrophobic monomers and they were tested against both strains of 
bacteria, among them polymers P6 (random block polymer) displayed potent activity against MRSA 
(1.5 µg/mL) and moderate activity (12.5µg/mL) against gram negative E. coli, similarly the diblock 
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polymers P5 displayed broad spectrum activity against MRSA (6 µg/mL) and E. coli (12.5 µg/mL). 
This result matched with our hypothesis that we propose the unimolecular micelle hyperbranched 
polymer with 20 equiv of hydrophilic and hydrophobic monomers might show broad spectrum 
activity. The broad-spectrum activity is probably obtained due to more interaction that is created 
between the hyperbranched polymers and the outer membrane of the Gram-negative bacteria with the 
increase of both hydrophilic and hydrophobic monomers in the arms of the Boltorn.  
               Encouraged by the MIC result of P5 and P6, we synthesized 6 more polymers by increasing 
the hydrophilic and hydrophobic residues. Diblock polymer P11 and random polymer P12 which had 
two times more hydrophilic and hydrophobic groups than the potent polymer P6 displayed lower 
antimicrobial activity. Diblock polymer P11 displayed 12 µg/mL MIC towards Gram positive bacteria 
and its activity totally lost against gram negative E. coli, similarly the random block polymer P12 
displayed lower activity towards Gram positive bacteria 6 µg/mL but the activity against Gram 
negative bacteria remains the same as polymer P6. The decreased activity of P11 and P12 might be 
caused by the reduced interaction of the cationic region of the polymer with the negatively charged 
bacterial membrane. From our findings we can propose that obtaining the desired amphiphilicity of 
the polymer is crucial for its antimicrobial potency and from the obtained data we were able to identify 
the number of equivalence of the hydrophobic and hydrophilic monomers required for potent and 
broad-spectrum activity. Consistent with the previous study in our lab,37 polymers developed from 20 
equiv of each hydrophilic and hydrophobic monomer showed potent and broad-spectrum activity.  
4.5 Conclusion 
In conclusion, we reported the design and development of potent antimicrobial unimolecular 
micelle hyperbranched polymers. A series of polymers were synthesized and tested for their 
antibacterial activity, and the MIC results disclose that the unimolecular unimicelle hyperbranched 
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polymers have broad-spectrum activity against both Gram-positive and Gram-negative bacteria 
especially the random block polymers.  Furthermore, from our finding we can conclude the potency 
of the polymers is determined by its amphiphilicity. This is because the interaction of the bacteria with 
a polymer depends on the nature of the amphiphilicity. Supplementary studies including hemolytic 
assay, biofilm assay and TEM will be done for the potent polymers to determine the mechanism of 
action of the polymers. Moreover, the design of unimolecular micelle is significant for synthesizing 
advanced polymers by incorporating distinct kinds of monomers and it may lead to the advance of a 
new class of antimicrobial polymers. 
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CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS 
Here, in Chapter 5 we sum up the research findings of the three projects presented in the 
previous chapters. We also propose some important ideas which could be helpful to further update 
those projects or related project. The three projects compiled in this thesis are all aimed to study and 
develop broad spectrum antibacterial biodegradable polymers including polycarbonate polymers, 
dendrimers and unimolecular nano particle micelles.  
We have developed biodegradable polycarbonates from both peptide and non-peptide 
analog monomers through a ring opening polymerization technique. Though the activity was not 
broad spectrum, the antibacterial activity and selectivity against clinically relevant and drug 
resistant Gram-positive bacteria was promising.  As our finding reveals, the incorporation of 
halogens in the polymer enhances the antibacterial activity, the present polymers could be further 
modified and designed so that broad spectrum could be achieved. The contemporary design can 
be obtained through incorporating a halogen group into similar bioactive peptides that encompass 
cationic and hydrophobic functional groups to make the monomer by itself amphiphilic. This 
design could potentially enhance the amphiphilicity of the whole polymer so that broad spectrum 
activity can be achieved.  
We have also designed and synthesized both lipidated dendrimers and hyperbranched 
unimolecular nanoparticle polymers as part of developing broad spectrum acting antimicrobial 
polymers. The dendrimers showed potent antibacterial activity towards Gram negative and Gram-
positive bacteria. Furthermore, these dendrimers could be developed for other biological 
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applications to treat various fungal and viral infections. It can also be manipulated as a drug 
delivery agent due to the presence of the internal voids in its structure.  
Lastly, our research study was focused in developing hyperbranched unimolecular 
nanoparticle polymers for antibacterial applications. The spatial architectural design of those micellar 
structures allows us to build more branches in the arms of the core and this allowed more interaction 
of the polymer and the bacterial membrane. A preliminary study has been done and the obtained result 
is promising; the polymers displayed broad spectrum activity. 
